Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03087877 · ClinicalTrials.gov registry record · NA
Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor
A NA study, sponsored by DexCom.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT03087877 is a NA study that has completed, run by DexCom. The registered enrollment target is 70 participants.
The verdict
NCT03087877, a NA study, has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The objective of the study is to demonstrate effectiveness of the G6 sensor membrane, in preventing acetaminophen's interference effect on glucose sensing.
Interventions
- DEVICE Acetaminophen Challenge (G6 CGM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2017-02-03 |
| Est. Completion | 2017-03-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03087877
The ClinicalTrials.gov registry entry for NCT03087877 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DexCom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acetaminophen Challenge (G6 CGM) is the first listed.
NCT03087877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03087877 about?
NCT03087877 is a clinical study titled "Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor". The objective of the study is to demonstrate effectiveness of the G6 sensor membrane, in preventing acetaminophen's interference effect on glucose sensing.
What is the current status of trial NCT03087877?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2017-02-03. Estimated completion is 2017-03-04.
What interventions are being tested in trial NCT03087877?
The interventions under investigation include: Acetaminophen Challenge (G6 CGM) (DEVICE).
Who is sponsoring clinical trial NCT03087877?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.